# Efficacy and Safety of XC8, Film-coated Tablets, in Children With Acute Respiratory Viral Infections

> **NCT06379542** · PHASE3 · UNKNOWN · sponsor: **Valenta Pharm JSC** · enrollment: 252 (estimated)

## Conditions studied

- Acute Respiratory Infection

## Interventions

- **DRUG:** XC8
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06379542
- **Lead sponsor:** Valenta Pharm JSC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-04
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 252 (ESTIMATED)
- **Last updated:** 2024-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06379542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06379542, "Efficacy and Safety of XC8, Film-coated Tablets, in Children With Acute Respiratory Viral Infections". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06379542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*